2-

-
2-
^ .. , ..
, .
- () . , , , . (Ephedra sinica) [1]. , , : , (, ) .
1900 ., , . 1904 . , (), - , . , , .. .
R. Alqhuist [2] 1948 . - - () -
-. , - 1 2-- ; - , ,-. 1967 . . . Lands et al. [3] -, , 2-.
2-
, 2-, . , 2-, , . 2- 90% 2- [4]. 2- , , , , . 2- -
2.20071 8

-
\ -
- \
,




'11'
+/++ " +/+


. 1. _- ([5], ).
2-, .
, 2- : 2- .
2- (. 1).
- , -, . (- ), , ( ), , , ,
2.2007-------------------
, () . 2- .
2- . , (. 2). 2- : , .
, 2-, - : -
-
.
: 2

:
22222 2222
3
: . 2. 2-.
, . , 2- () , . , 2- () , , , , 2- .
2- : - . , 2-, , , .
2- , ( ).
2- , .
2- , ; - . . , 2-- .
, 2--. , , , (, ) (-) (-) . 2- - - . - : -

~

X
, 4



2- |

. 3. 2- ([5], ).
, , -- ., - [6]. 2004 . 2-, -. ( 8 ) [7]. 2007 . , -. , .
2- , , -
2.2007------------------
2-, - . , ( ), - ( - -), - , , (. 3).
2-
2- : .
2- , , , ,
-
, (-). () . 2- - , 46 . 2- [8].
2- , , ( ).
2-- (, ). 2- : ( ) -, . 2- 2- . - 2- , , , , ( ) .
2- , ( 2-),
2- , . 12 , 2 .
: - 35 , - 1520 . 2-: - 2-, [9]. , - [10].
2- . , , , 2-- - (- ) [11].
2-
, 2--, - . . , , , , . (, 2- ).
2- . , 2- . , , 12000 , 2-- ( , ) ; 2- - [12]. , 1700 , 2- (); , 2- [13].
, , 2- [14, 15]. SMART (The Salmeterol Multicenter Asthma Research Trial), , 2006 . (FDA, ) , 2- . [16].
,
: () , 2-.
2- , :
2- ;
2- , ;
, 2- , ( );
2- ;
2- ;
, , .
2-
2-- ( , )
'-
( -
). 2- :
2- ( 46 ) , () / ;
2- ;
2- (, ), -.
2- () . , 2- (, -), , , , , , [17-19].

2- (- ) - 2- [20].
( ) 2- , , , , , - [21].
2- (<500 / ) [22].
2-
, ( - , , ), .
, , 2- .

2.2007
2- ( 2-4 20 ); 2-5 2-3 .
2--. , . , .
[22]. , 2-- [23].
-- . , 2- . 2- - . , - , , ( <90%) 2-- , .
2-
2- . 2- : -, ().
, 2- / . , .
, , [24]. .
, , . , , . , , , . , , , - 21-59% [24],
-
. 2- .
- () - , . . ( , ) .
: . , ( , .) . , , , .
: . - ( , ) . , , . 2- -, 2- - . ,
( ).
2-
Novartis 2- . ( 24 ) [25].
( Beyond Advair) , GlaxoSmithKline Theravance [26].
, 2-, , . 2- , , , .

1. http://www.botgard.ucla.edu
2. Black J.W. Ahlquist and the development of beta-adrenoceptor antagonists // Postgrad. Med. J. 1976. V. 52. Suppl. 4. P. 11-13.
3. Lands A.M., Arnold A., McAuliff J.P. et al. Differentiation of receptor systems activated by sympathomimetic amines // Nature. 1967. V. 214. P. 597-598.
4. Bertram J.F., Goldie R.G., Papadimitriou J.M. et al. Correlations between pharmacological responses and structure of human lung parenchyma strips // Br. J. Pharmacol. 1983. V. 80. P. 107-114.
5. Barnes P. -Agonists, anticholinergics, and other nonsteroid drugs // Comprehensive Respiratory
---------------------- 2.2007
Medicine / Ed. by Spiro S.G., JettJ.R., Albert R.K. L., 2001. P. 34.1-34.10.
6. Johansson F., Rydberg I., Aberg G. et al. Effects of albuterol enantiomers on in vitro bronchial reactivity // Clin. Rev. Allergy Immunol. 1996. V. 14. P. 57-64.
7. Dhand R., Goode M., Reid R. et al. Preferential pulmonary retention of (S)-albuterol after inhalation of racemic albuterol // Amer. J. Respir. Crit. Care Med. 1999. V. 160. P. 1136-1141.
8. Mugge A., Posselt D., Reimer U. et al. Effects of the P2-adrenoceptor agonists, fenoterol and
salbutamol, on force of contraction in isolated human ventricular myocardium // Klin. Wochenschr. 1985. V. 63. P. 26-31.
9. Naline E., Zhang Y., Qian Y. et al. Relaxant effects and durations of action of formoterol and salmeterol on the isolated human bronchus // Eur. Respir. J. 1994. V. 7. P. 914-920.
10. Cazzola M., Matera M.G., Santangelo G. et al. Salmeterol and formoterol in partially reversible severe chronic obstructive pulmonary disease: a dose-response study // Respir. Med. 1995. V. 89. P. 357-362.
11. Cheung D., Timmers M., Zwinderman A.H. Long-term effects of a long-acting beta2-adre-noceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma // N. Engl. J. Med. 1992. V. 327. P. 1198-1203.
12. Spitzer W.O., Suissa S., Ernst P. et al. The use of beta-agonists and the risk of death and near death from asthma // N. Engl. J. Med. 1992. V. 326. P. 501-506.
13. Mullen M., Mullen B., Carey M. The association between beta-agonist use and death from asthma. A meta-analytic integration of case-control studies // JAMA. 1993. V. 270. P. 1842-1845.
14. Castle W., Fuller R., Hall J. et al. Serevent nationwide surveillance study: comparison of salmeterol with salbutamol in asthmatic patients who require regular bronchodilator treatment // Br. Med. J. 1993. V. 306. P. 1034-1037.
15. Nelson H.S., Weiss S.T, Bleecker E.R. et al. The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salme-terol // Chest. 2006. V. 129. P. 15-26.
16. http://www.fda.gov
17. Chroinin M.N., Greenstone I.R., Ducharme F.M. Addition of inhaled long-acting
beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults // Cochrane Database of Systematic Reviews. 2004. Issue 4. Art. CD005307.
18. Greenstone I.R., Chroinin M.N., Masse V. et al. Combination of inhaled long-acting beta2-ago-nists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma // Cochrane Database of Systematic Reviews. 2005. Issue 4. Art. CD005533.
19. Chroinin M.N., Greenstone I.R., Danish A. et al. Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma // Cochrane Database of Systematic Reviews. 2005. Issue 4. Art. CD005535.
20. Shah L., Wilson A.J., Gibson P.G. et al. Long-acting beta2-agonists versus theophylline for maintenance treatment of asthma // Cochrane Database of Systematic Reviews. 2003. Issue 3. Art. CD001281.
21. Ducharme F.M., Lasserson TJ., Cates C.J. Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma // Cochrane Database of Systematic Reviews. 2006. Issue 4. Art. CD003137.
22. GINA Workshop Report: Global Strategy for Asthma Management and Prevention (Updated 2006) // http://www.ginaasthma.org
23. Rubinfeld A.R., Scicchitano R., Hunt A. et al. Formoterol Turbuhaler as reliever medication in patients with acute asthma // Eur. Respir. J. 2006. V. 27. P. 735-741.
24. Ram F.S., Brocklebank D.M., White J. et al. Pressurized metered dose inhalers versus all other hand-held inhaler devices to deliver beta-2 agonist bronchodilators for non-acute asthma // Cochrane Database of Systematic Reviews. 2002. Issue 2. Art. CD002158.
25. New data show that Novartis indacaterol provides 24-hour efficacy with single dose in patients with asthma and COPD. Media release of September 19, 2005 // http://www.novartis.com
26. http://www.theravance.com/programs/ asthma_copd.php